GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · IEX Real-Time Price · USD
9.64
+0.07 (0.73%)
Apr 19, 2024, 4:00 PM EDT - Market closed
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $251.16 million as of April 19, 2024. Its market cap has increased by 8.21% in one year.
Market Cap
251.16M
Enterprise Value
240.28M
1-Year Change
8.21%
Ranking
Category
Stock Price
$9.64
Market Cap Chart
Since September 2, 2020, GeneDx Holdings's market cap has decreased from $448.40M to $251.16M, a decrease of -43.99%. That is a compound annual growth rate of -14.77%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 18, 2024 | 249.30M | 4.01% |
Apr 17, 2024 | 239.70M | -4.27% |
Apr 16, 2024 | 250.40M | -2.72% |
Apr 15, 2024 | 257.40M | 2.71% |
Apr 12, 2024 | 250.60M | -14.03% |
Apr 11, 2024 | 291.50M | -3.22% |
Apr 10, 2024 | 301.20M | 6.66% |
Apr 9, 2024 | 282.40M | 3.82% |
Apr 8, 2024 | 272.00M | 4.49% |
Apr 5, 2024 | 260.30M | 10.39% |
Apr 4, 2024 | 235.80M | -4.22% |
Apr 3, 2024 | 246.20M | 1.28% |
Apr 2, 2024 | 243.10M | 3.31% |
Apr 1, 2024 | 235.30M | -1.09% |
Mar 28, 2024 | 237.90M | -3.49% |
Mar 27, 2024 | 246.50M | 8.26% |
Mar 26, 2024 | 227.70M | 3.08% |
Mar 25, 2024 | 220.90M | -1.52% |
Mar 22, 2024 | 224.30M | -6.23% |
Mar 21, 2024 | 239.20M | 7.89% |
Mar 20, 2024 | 221.70M | 1.05% |
Mar 19, 2024 | 219.40M | -12.83% |
Mar 18, 2024 | 251.70M | -19.56% |
Mar 15, 2024 | 312.90M | 10.49% |
Mar 14, 2024 | 283.20M | 1.58% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Fennec Pharmaceuticals | 259.35M |
Verastem | 258.77M |
Ventyx Biosciences | 257.75M |
Boundless Bio | 251.30M |
Werewolf Therapeutics | 250.87M |
AEON Biopharma | 249.31M |
Xeris Biopharma Holdings | 247.20M |
AngioDynamics | 245.13M |